Diasorin, headquartered in Italy and listed on the Italian Stock Exchange, is a global leader in In Vitro Diagnostics (IVD) and Life Sciences. With over 50 years of experience, the company develops and markets reagent kits used by diagnostic laboratories worldwide. Operating in 35 countries with 10 manufacturing facilities and 9 R&D centers, Diasorin offers a wide range of specialty tests. With over 3,200 employees, the company is committed to improving healthcare and fostering innovation in the global medical field.